tiprankstipranks
Cynata Therapeutics Limited (AU:CYP)
ASX:CYP

Cynata Therapeutics Limited (CYP) Technical Analysis

1 Followers

Summary of all the Indicators

Overall Consensus
Strong Buy
16Bullish
4Neutral
1Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
1Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Cynata Therapeutics Limited’s (CYP) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Cynata Therapeutics Limited is a Buy.
Cynata Therapeutics Limited’s (CYP) 20-Day exponential moving average is 0.18, while Cynata Therapeutics Limited’s (CYP) share price is AU$0.175, making it a Buy.
Cynata Therapeutics Limited’s (CYP) 50-Day exponential moving average is 0.17, while Cynata Therapeutics Limited’s (CYP) share price is AU$0.175, making it a Buy.

Cynata Therapeutics Limited (CYP) Pivot Points

Mar 29, 2024, 05:48 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.16
0.17
0.17
0.18
0.19
0.20
0.20
Fibonacci
0.17
0.17
0.17
0.18
0.19
0.19
0.20
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Cynata Therapeutics Limited (CYP) Moving Averages

Mar 29, 2024, 05:48 AM
Period
Simple
Exponential
MA5
0.18Buy
0.18Buy
MA10
0.18Buy
0.18Buy
MA20
0.18Buy
0.18Buy
MA50
0.17Buy
0.17Buy
MA100
0.15Buy
0.16Buy
MA200
0.14Buy
0.15Buy
Cynata Therapeutics Limited’s (CYP) 10-Day exponential moving average is 0.18, while Cynata Therapeutics Limited’s (CYP) share price is AU$0.175, making it a Buy.
Cynata Therapeutics Limited’s (CYP) 100-Day exponential moving average is 0.16, while Cynata Therapeutics Limited’s (CYP) share price is AU$0.175, making it a Buy.
Cynata Therapeutics Limited’s (CYP) stock price is AU$0.175 and Cynata Therapeutics Limited’s (CYP) 50-day simple moving average is 0.17, creating a Buy signal.
Cynata Therapeutics Limited’s (CYP) stock price is AU$0.175 and Cynata Therapeutics Limited’s (CYP) 100-day simple moving average is 0.15, creating a Buy signal.
Cynata Therapeutics Limited’s (CYP) stock price is AU$0.175 and Cynata Therapeutics Limited’s (CYP) 200-day simple moving average is 0.14, creating a Buy signal.

Cynata Therapeutics Limited (CYP) Technical Indicators

Mar 29, 2024, 05:48 AM
Name
Value
Implied Action
RSI (14)
54.03
Neutral
STOCH (9,6)
85.71
Sell
STOCHRSI (14)
54.55
Neutral
MACD (12,26)
<0.01
Buy
ADX (14)
15.67
Buy
Williams %R
-36.36
Buy
CCI (14)
24.42
Neutral
ATR (14)
0.02
-
Ultimate Oscillator
58.43
Neutral
ROC
0.00
-
Cynata Therapeutics Limited’s (CYP) Relative Strength Index (RSI) is 54.03, creating a Neutral signal.
Cynata Therapeutics Limited’s (CYP) Trend Strength Indicator (ADX) is 15.67, creating a Buy signal.
Cynata Therapeutics Limited’s (CYP) Commodity Channel Index (CCI) is 24.42, creating a Neutral signal.

FAQ

Is CYP a Buy, Hold, or Sell?
Based on CYP’s technical indicators, CYP is a Strong Buy.
    What is CYP’s RSI (14)?
    CYP’s RSI (14) is 54.03, which suggests CYP is a Neutral.
      What is CYP’s MACD?
      CYP’s MACD is <0.01, which suggests CYP is a Buy.
        What is CYP’s 5-day moving average?
        CYP’s 5-day moving average is 0.18, which suggests CYP is a Buy.
          What is CYP’s 20-day moving average?
          CYP 20-day moving average is 0.18, which suggests CYP is a Buy.
            What is CYP’s 50-day moving average?
            CYP’s 50-day moving average is 0.17, which suggests CYP is a Buy.
              What is CYP’s 200-day moving average?
              CYP’s 200-day moving average is 0.14, which suggests CYP is a Buy.
                What is CYP’s Williams % R (14)?
                CYP’s Williams % R (14) is -36.36, which suggests CYP is a Buy.
                  What is CYP’s CCI (14)?
                  CYP’s CCI (14) is 24.42, which suggests CYP is a Neutral.
                    What is the share price of Cynata Therapeutics Limited?
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis